Results for tag: "Anthrax Vaccine"

The Anthrax Vaccine is a vaccine used to protect against the deadly bacterial disease anthrax. It is a recombinant protective antigen (rPA) vaccine, which is composed of a single protein antigen derived from the bacterium that causes anthrax. The vaccine is administered in a series of three doses, with the second and third doses given at two and four weeks after the first dose. The vaccine is approved for use in adults and children over the age of 18 months. The Anthrax Vaccine market is a small but important part of the overall Vaccines market. It is used to protect against a potentially deadly disease, and is an important part of public health initiatives. The vaccine is used in both the military and civilian populations, and is often used in combination with other vaccines. Companies in the Anthrax Vaccine market include Emergent BioSolutions, Bavarian Nordic, and GlaxoSmithKline. Show Less Read more